Full Press Release Details
IDEAYA Biosciences Announces Option and License Agreement for Potential First in Class B7H3 PTK7 Topo I Payload Bispecific ADC Program with Biocytogen.
IDYA
IDEAYA Biosciences Announces Option and License Agreement for Potential First in Class B7H3 PTK7 Topo I Payload Bispecific ADC Program with Biocytogen
Key Takeaway: IDEAYA Biosciences Announces Option and License Agreement for Potential First in Class B7H3 PTK7 Topo I Payload Bispecific ADC Program with Biocytogen